ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+19.3%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$346M
AUM Growth
+$346M
(+37%)
Cap. Flow
+$50.3M
Cap. Flow
% of AUM
14.51%
Top 10 Holdings %
Top 10 Hldgs %
28.92%
Holding
101
New
22
Increased
17
Reduced
25
Closed
18
Top Buys
| 1 |
WW
WW International
WW
|
$12.1M |
| 2 |
PVTL
Pivotal Software, Inc.
PVTL
|
$7.89M |
| 3 |
Roku
ROKU
|
$6.82M |
| 4 |
Ashland
ASH
|
$6.65M |
| 5 |
GRA
W.R. Grace & Co.
GRA
|
$6.53M |
Top Sells
| 1 |
Goldman Sachs
GS
|
$5.92M |
| 2 |
Atlassian
TEAM
|
$5.39M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$4.94M |
| 4 |
RHT
Red Hat Inc
RHT
|
$3.49M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$3.46M |
Sector Composition
| 1 | Healthcare | 39.57% |
| 2 | Technology | 21.4% |
| 3 | Communication Services | 17.75% |
| 4 | Consumer Discretionary | 15.24% |
| 5 | Materials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Penumbra
PEN
$10.6B
| $3.11M | 0.6% |
22,500
-6,000
| -21% | -$829K |
|
52
CRISPR Therapeutics
CRSP
$4.71B
| $3.06M | 0.59% |
+52,000
| New | +$3.06M |
|
|
BLUE
53
DELISTED
bluebird bio
BLUE
| $2.9M | 0.56% |
18,500
-5,500
| -23% | -$863K |
|
54
NovoCure
NVCR
$1.38B
| $2.82M | 0.54% |
+90,000
| New | +$2.82M |
|
55
Floor & Decor
FND
$8.82B
| $2.71M | 0.52% |
55,000
-32,600
| -37% | -$1.61M |
|
|
TSG
56
DELISTED
The Stars Group Inc.
TSG
| $2.54M | 0.49% |
+70,000
| New | +$2.54M |
|
57
Q2 Holdings
QTWO
$4.92B
| $2.37M | 0.46% |
41,500
-21,500
| -34% | -$1.23M |
|
58
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.27M | 0.44% |
23,000
-18,000
| -44% | -$1.77M |
|
|
ZGNX
59
DELISTED
Zogenix, Inc.
ZGNX
| $2.21M | 0.43% |
50,000
| – | – |
|
60
Vertex Pharmaceuticals
VRTX
$100B
| $2.04M | 0.39% |
12,000
-3,000
| -20% | -$510K |
|
|
MNTA
61
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.82M | 0.35% |
+89,000
| New | +$1.82M |
|
62
Veeva Systems
VEEV
$44B
| $1.54M | 0.3% |
20,000
-5,000
| -20% | -$384K |
|
|
ATVI
63
DELISTED
Activision Blizzard Inc.
ATVI
| $1.37M | 0.26% |
18,000
-14,000
| -44% | -$1.07M |
|
64
Ascendis Pharma
ASND
$11.8B
| $1.04M | 0.2% |
+15,700
| New | +$1.04M |
|
|
RHT
65
DELISTED
Red Hat Inc
RHT
| $671K | 0.13% |
5,000
-26,000
| -84% | -$3.49M |
|
|
MDCO
66
DELISTED
Medicines Co
MDCO
| $396K | 0.08% |
+10,813
| New | +$396K |
|
67
Cognizant
CTSH
$35.3B
| – | – |
0
| – | – |
|
68
Designer Brands
DBI
$181M
| – | – |
-96,000
| Closed | -$2.16M |
|
69
Dine Brands
DIN
$368M
| – | – |
0
| – | – |
|
70
DocuSign
DOCU
$15.5B
| – | – |
0
| – | – |
|
71
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
0
| – | – |
|
72
Esperion Therapeutics
ESPR
$448M
| – | – |
-40,000
| Closed | -$2.89M |
|
73
Amicus Therapeutics
FOLD
$2.34B
| – | – |
-100,000
| Closed | -$1.5M |
|
|
AERI
74
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
0
| – | – |
|
75
Cognex
CGNX
$7.38B
| – | – |
-32,000
| Closed | -$1.66M |
|